Philips reiterates FY25 outlook following steady Q3 performance

Philips has maintained 2025 guidance after AI-powered innovation and sustained strength in the North American market powered Q3 comparable sales growth. The Dutch medtech giant stated it is maintaining its fiscal year 2025 (FY25) outlook of growth between 1% to 3% following steady performance across its business segments in Q3 2025 after total revenues were revealed at €4.3bn for Q3, reflecting a drop of around 1.7% on the same period in 2024 at around €4.37bn. However, Philips’ comparable sales in Q3 gr ...